OQ2 Stock Overview
Provides components and systems solutions for motion and positioning in Sweden and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Acuvi AB Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 1.23 |
| 52 Week High | SEK 1.49 |
| 52 Week Low | SEK 0.60 |
| Beta | 1.08 |
| 11 Month Change | -11.78% |
| 3 Month Change | -9.31% |
| 1 Year Change | 84.66% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -56.61% |
Recent News & Updates
Recent updates
Shareholder Returns
| OQ2 | DE Electrical | DE Market | |
|---|---|---|---|
| 7D | 1.3% | 1.5% | -1.3% |
| 1Y | 84.7% | 132.3% | 7.4% |
Return vs Industry: OQ2 underperformed the German Electrical industry which returned 125.3% over the past year.
Return vs Market: OQ2 exceeded the German Market which returned 7.1% over the past year.
Price Volatility
| OQ2 volatility | |
|---|---|
| OQ2 Average Weekly Movement | 5.6% |
| Electrical Industry Average Movement | 5.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: OQ2 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: OQ2's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 54 | Olof Stranding | www.acuvi.com |
Acuvi AB provides components and systems solutions for motion and positioning in Sweden and internationally. The company provides solutions in the field of life science instrumentation, semicon, medtech, and advanced industrial. Its products are primarily used in advanced microscopy and imaging, microfluids, semiconductor, manufacturing, and advanced optics.
Acuvi AB Fundamentals Summary
| OQ2 fundamental statistics | |
|---|---|
| Market cap | €37.63m |
| Earnings (TTM) | -€8.63m |
| Revenue (TTM) | €17.88m |
2.1x
P/S Ratio-4.4x
P/E RatioIs OQ2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OQ2 income statement (TTM) | |
|---|---|
| Revenue | SEK 207.29m |
| Cost of Revenue | SEK 79.04m |
| Gross Profit | SEK 128.26m |
| Other Expenses | SEK 228.28m |
| Earnings | -SEK 100.02m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.39 |
| Gross Margin | 61.87% |
| Net Profit Margin | -48.25% |
| Debt/Equity Ratio | 10.5% |
How did OQ2 perform over the long term?
See historical performance and comparison